Tolerogenic dendritic cells and the quest for transplant tolerance

Nature Reviews Immunology

Volumn 7, Issue 8, 2007, Pages 610-621

  Morelli, Adrian E ^a,b   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCITRIOL; CORTICOSTEROID; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; FK 506 BINDING PROTEIN; GLUCOSAMINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; LF 15 0915; LF15 0195; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD1547; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN E2; PROTOPORPHYRIN; RAPAMYCIN; SANGLIFEHRIN A; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANTIGEN RECOGNITION; APOPTOSIS; CD4+ CD25+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CLONAL ANERGY; DENDRITIC CELL; DRUG EFFECT; GENETIC ENGINEERING; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TRANSPLANTATION TOLERANCE;

ANIMALS; CELL DIFFERENTIATION; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOTHERAPY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 34547152610     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2132     Document Type: Review

References (131)

1. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
2. Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003).
3. Shortman, K. & Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nature Rev. Immunol. 7, 19-30 (2007). References 2 and 3 are comprehensive and authoritative reviews of DC subsets and DC tolerogenicity.
4. Vremec, D., Pooley, J., Hochrein, H., Wu, L. & Shortman, K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978-2986 (2000).
5. Henri, S. et al. The dendritic cell populations of mouse lymph nodes. J. Immunol.167, 741-748 (2001).
6. Corcoran, L. et al. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J. Immunol. 170, 4926-4932 (2003).
7. Shortman, K. & Liu, Y. J. Mouse and human dendritic cell subtypes. Nature Rev. Immunol. 2, 151-161 (2002).
8. Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nature Immunol. 2, 1144-1150 (2001).
9. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194, 1171-1178 (2001).
10. Bjorck, P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98, 3520-3526 (2001).
11. Yrlid, U. & Macpherson, G. Phenotype and function of rat dendritic cell subsets. APMIS 111, 756-765 (2003).
12. Brocker, T., Riedinger, M. & Karjalainen, K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185, 541-550 (1997).
13. Menges, M. et al. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15-21 (2002).
14. + T cells. J. Immunol. 174, 7433-7439 (2005).
15. Hackstein, H. & Thomson, A. W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nature Rev. Immunol. 4, 24-35 (2004). A detailed survey of how pharmacological agents regulate DC differentiation and maturation and promote their tolerogenic properties.
16. Morelli, A. E. & Thomson, A. W. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196, 125-146 (2003).
17. Chauveau, C. et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106, 1694-1702 (2005).
18. Hackstein, H. et al. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101, 4457-4463 (2003).
19. + T regulatory cells and promote organ transplant tolerance. J. Immunol. 178, 7018-7031 (2007).
20. Min, W. P. et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J. Immunol. 170, 1304-1312 (2003).
21. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405-2411 (2000).
22. Griffin, M. D. et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 270, 701-708 (2000).
23. H2-inducing cytokines. J. Exp. Med. 195, 603-616 (2002).
24. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945-1953 (2001).
25. Liang, S. & Horuzsko, A. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum. Immunol. 64, 1025-1032 (2003).
26. Bonham, C. A. et al. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol. 169, 3382-3391 (2002).
27. Hill, J. A. et al. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J. Immunol. 171, 691-696 (2003).
28. Maraskovsky, E. et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953-1962 (1996).
29. Pulendran, B. et al. Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant. J. Exp. Med. 188, 2075-2082 (1998).
30. Coates, P. T. et al. Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood 102, 2513-2521 (2003).
31. Eto, M., Hackstein, H., Kaneko, K., Nomoto, K. & Thomson, A. W. Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions. J. Immunol. 169, 2390-2396 (2002).
32. Antonysamy, M. A. et al. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. J. Immunol. 160, 4106-4113 (1998).
33. Hackstein, H. et al. Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154). Am. J. Transplant. 2, 609-617 (2002).
34. Coates, P. T. et al. In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation 77, 1080-1089 (2004).
35. Steptoe, R. J. et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J. Immunol. 159, 5483-5491 (1997).
36. Arpinati, M., Green, C. L., Heimfeld, S., Heuser, J. E. & Anasetti, C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95, 2484-2490 (2000).
37. Gould, D. S. & Auchincloss, H. Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20, 77-82 (1999).
38. Herrera, O. B. et al. A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 173, 4828-4837 (2004).
39. + T cells by dendritic cell-derived exosomes. Nature Immunol. 3, 1156-1162 (2002).
40. Harshyne, L. A., Watkins, S. C., Gambotto, A. & Barratt-Boyes, S. M. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 166, 3717-3723 (2001).
41. Mueller, D. L., Jenkins, M. K. & Schwartz, R. H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-480 (1989).
42. dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60, 1539-1545 (1995).
43. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62, 659-665 (1996). The first account of the ability of immature myeloid DCs of donor origin to prolong organ allograft survival.
44. Lutz, M. B. et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30, 1813-1822 (2000). Describes how maturation-resistant DCs can induce indefinite organ allograft survival.
45. + regulatory T cells by inhibition of APC proteosome function. J. Immunol. 174, 2787-2795 (2005).
46. Wakkach, A. et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18, 605-617 (2003).
47. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247 (2003).
48. + regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl Acad. Sci. USA 103, 2758-2763 (2006).
49. Reg cells suppress autoimmune disease.
50. Rastellini, C. et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60, 1366-1370 (1995).
51. Lu, L. et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64, 1808-1815 (1997).
52. Niimi, M. et al. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway. Transplantation 72, 1556-1562 (2001).
53. Hayamizu, K., Huie, P., Sibley, R. K. & Strober, S. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation 66, 1285-1291 (1998).
54. Selenko-Gebauer, N. et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170, 3637-3644 (2003).
55. Munn, D. H. et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867-1870 (2002).
56. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100-4110 (2004).
57. S cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nature Immunol. 3, 237-243 (2002).
58. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99, 2468-2476 (2002).
59. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222 (2000).
60. R cells. Blood 105, 1162-1169 (2005).
61. Suss, G. & Shortman, K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis. J. Exp. Med. 183, 1789-1796 (1996).
62. + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099-1104 (2002).
63. Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107-111 (2007).
64. Grohmann, U. et al. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J. Immunol. 166, 277-283 (2001).
65. + subset. J. Immunol. 165, 1357-1363 (2000).
66. Reg cells on DCs augments functional IDO expression.
67. Belladonna, M. L. et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J. Immunol. 177, 130-137 (2006).
68. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097-1101 (2002).
69. Mellor, A. L. & Munn, D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev. Immunol. 4, 762-774 (2004).
70. + dendritic cells prolong the survival of vascularized heart allografts. J. Immunol. 168, 143-154 (2002).
71. Siegal, F. P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999).
72. Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869 (2001).
73. Rissoan, M. C. et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186 (1999).
74. + regulatory T cells. J. Immunol. 173, 4433-4442 (2004).
75. Gilliet, M. & Liu, Y. J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695-704 (2002).
76. Ito, T. et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105-115 (2007). References 74-76 show how pDCs can generate different types of regulatory T cells.
77. Fallarino, F. et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173, 3748-3754 (2004).
78. Grohmann, U. et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nature Med. 13, 579-586 (2007).
79. Fugier-Vivier, I. J. et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201, 373-383 (2005).
80. Abe, M., Wang, Z., De Creus, A. & Thomson, A. W. Plasmacytoid dendritic cell precursors induce allogeneic T cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5, 1808-1819 (2005).
81. Inaba, K. et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163-2173 (1998).
82. Yu, G., Xu, X., Vu, M. D., Kilpatrick, E. D. & Li, X. C. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J. Exp. Med. 203, 1851-1858 (2006).
83. Garrovillo, M., Ali, A. & Oluwole, S. F. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Transplantation 68, 1827-1834 (1999). The first report that alloantigen-pulsed host DCs can be used to induce alloantigen-specific organ transplant tolerance.
84. Ali, A., Garrovillo, M., Jin, M. X., Hardy, M. A. & Oluwole, S. F. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells. Transplantation 69, 221-226 (2000).
85. Oluwole, O. O. et al. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 50, 1546-1552 (2001).
86. Taner, T., Hackstein, H., Wang, Z., Morelli, A. E. & Thomson, A. W. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 5, 228-236 (2005).
87. Peche, H., Trinite, B., Martinet, B. & Cuturi, M. C. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am. J. Transplant. 5, 255-267 (2005).
88. Beriou, G., Peche, H., Guillonneau, C., Merieau, E. & Cuturi, M. C. Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression. Transplantation 79, 969-972 (2005).
89. Sato, K., Yamashita, N., Yamashita, N., Baba, M. & Matsuyama, T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18, 367-379 (2003).
90. Reg cells in vitro that promote transplant tolerance.
91. + regulatory T cells ex vivo. Blood 102, 2180-2186 (2003).
92. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. & Bhardwaj, N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238 (2001). A proof-of-principle study that shows that immature autologous DCs pulsed with nominal antigen can induce antigen-specific T-cell tolerance in healthy volunteers.
93. Ochando, J. C. et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nature Immunol. 7, 652-662 (2006).
94. Baban, B. et al. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int. Immunol. 17, 909-919 (2005).
95. Mellor, A. L. et al. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 16, 1391-1401 (2004).
96. + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J. Immunol. 175, 5601-5605 (2005).
97. Mirenda, V. et al. Modified dendritic cells coexpressing self and allogeneic major histocompatibility complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 15, 987-997 (2004).
98. Garrod, K. R. et al. Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival. J. Immunol. 177, 863-868 (2006).
99. Matsue, H. et al. Immunosuppressive properties of CD95L-transduced 'killer' hybrids created by fusing donor- and recipient-derived dendritic cells. Blood 98, 3465-3472 (2001).
100. Morelli, A. E. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am. J. Transplant. 6, 254-261 (2006).
101. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779 (2001). The first documentation that in situ targeting of DCs with monoclonal antibodies and antigen in the steady state is associated with antigen-specific T-cell tolerance.
102. + T cell tolerance. J. Exp. Med. 196, 1627-1638 (2002).
103. Larregina, A. T. & Morelli, A. E. in Handbook of Dendritic Dells: Biology, Diseases, and Therapies (eds Lutz, M. B., Romani, N. & Steinkasserer, A.) 591-618 (Wiley-VCH, Weinheim, 2006).
104. Morelli, A. E. et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101, 611-620 (2003).
105. Wang, Z. et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am. J. Transplant. 6, 1297-1311 (2006). The first report that in situ targeting of DCs with donor-derived apoptotic cells prolongs solid organ allograft survival.
106. Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nature Rev. Immunol. 2, 569-579 (2002).
107. Morelli, A. E. et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104, 3257-3266 (2004).
108. Peche, H. et al. Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am. J. Transplant. 6, 1541-1550 (2006).
109. Qian, S., Thai, N. L., Lu, L., Fung, J. J. & Thomson, A. W. Liver transplant tolerance: mechanistic insights from animal models with particular reference to the mouse. Transplant. Rev. 11, 151-164 (1997).
110. Crispe, I. N. Hepatic T cells and liver tolerance. Nature Rev. Immunol. 3, 51-62 (2003).
111. Pillarisetty, V. G., Miller, G., Shah, A. B. & DeMatteo, R. P. GM-CSF expands dendritic cells and their progenitors in mouse liver. Hepatology 37, 641-652 (2003).
112. Sun, J., McCaughan, G. W., Gallagher, N. D., Sheil, A. G. & Bishop, G. A. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 60, 233-236 (1995).
113. Shimizu, Y. et al. Restoration of tolerance to rat hepatic allografts by spleen-derived passenger leukocytes. Transpl. Int. 9, 593-595 (1996).
114. Lu, L. et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allgraft recipients in response to granulocyte/macrophage colony stimulating factor. J. Exp. Med. 182, 379-387 (1995). The novel finding that donor-derived DCs can be propagated from the bone marrow of animals that show spontaneous liver transplant tolerance but not from those that acutely reject heart allografts.
115. Demetris, A. et al. Analysis of chronic rejection and obliterative arteriolopathy. Possible contributions of donor antigen presenting cells and lymphatic disruption. Am. J. Pathol. 150, 563 (1997).
116. Qian, S. et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J. Immunol. 158, 4654-4661 (1997).
117. Sharland, A. et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation 68, 1736-1745 (1999).
118. Li, W. et al. IL-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J. Immunol. 166, 5619-5628 (2001).
119. Randow, F. et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J. Exp. Med. 181, 1887-1892 (1995).
120. van der Poll, T., Coyle, S. M., Moldawer, L. L. & Lowry, S. F. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J. Infect. Dis. 174, 1356-1360 (1996).
121. Dobrovolskaia, M. A. & Vogel, S. N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4, 903-914 (2002).
122. Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202 (2002).
123. Medvedev, A. E., Lentschat, A., Wahl, L. M., Golenbock, D. T. & Vogel, S. N. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169, 5209-5216 (2002).
124. Nakagawa, R. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677-687 (2002).
125. Ziegler-Heitbrock, H. W. Molecular mechanism in tolerance to lipopolysaccharide. J. Inflamm. 45, 13-26 (1995).
126. Wysocka, M. et al. IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J. Immunol. 166, 7504-7513 (2001).
127. Tinsley, K. W. et al. Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J. Immunol. 171, 909-914 (2003).
128. De Creus, A. et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 174, 2037-2045 (2005).
129. H1-type responses. Eur. J. Immunol. 36, 2483-2493 (2006).
130. Ishiyama, K. et al. Induction of endotoxin tolerance inhibits alloimmune responses. Transpl. Immunol. 16, 158-165 (2006).
131. Liew, F. Y., Xu, D., Brint, E. K. & O'Neill L, A. Negative regulation of Toll-like receptor-mediated immune responses. Nature Rev. Immunol. 5, 446-458 (2005).